TrademarkDir
QARZIBA
LIVE

Serial Number

79167604

Owner

EUSA PHARMA (UK) LIMITED

Attorney

Mainak H. Mehta

Filing Date

Mar 24, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

QARZIBA Trademark

Serial Number: 79167604 • Registration: 4887381

QARZIBA is a trademark filed by EUSA PHARMA (UK) LIMITED on March 24, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

EUSA PHARMA (UK) LIMITED (8 trademarks)

Ground Floor Suite F
Hemel Hempstead HP24TZ , GB

Entity Type: 16

APEIRON BIOLOGICS AG (10 trademarks)

Campus-Vienna-Biocenter 5

Entity Type: 99

Recordati UK Limited

Breakspear Park,

Entity Type: 98

Trademark Details

Filing Date

March 24, 2015

Registration Date

January 19, 2016

Published for Opposition

November 3, 2015

Cancellation Date

March 25, 2025

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of cancer; diagnostic preparations for medical purposes; sanitary preparations for medical purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 19, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 19, 2026 NREP
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 10, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Oct 10, 2025 DETH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 31, 2025 ADCH
TOTAL INVALIDATION PROCESSED BY THE IB
Aug 24, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 1, 2024 INTS
INVALIDATION PROCESSED
Aug 1, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 11, 2024 INTR
NOTICE OF CANCELLATION SEC. 71 E-MAILED
Nov 11, 2023 NC71
CANCELLED SECTION 71
Nov 10, 2023 C71T
POST REGISTRATION ACTION MAILED - SEC.71
Feb 11, 2023 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 19, 2023 APRE
TEAS SECTION 71 RECEIVED
Jul 15, 2022 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 19, 2021 REM3
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 18, 2017 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Mar 10, 2017 RHRD
CHANGE OF OWNER RECEIVED FROM IB
Mar 2, 2017 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Dec 8, 2016 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 9, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 20, 2016 FICS
FINAL DISPOSITION PROCESSED
Apr 20, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 19, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 19, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 3, 2015 NPUB
PUBLISHED FOR OPPOSITION
Nov 3, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 14, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 25, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2015 CRFA
ASSIGNED TO LIE
Sep 8, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 24, 2015 TROA
REFUSAL PROCESSED BY IB
Aug 1, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 10, 2015 RFCS
REFUSAL PROCESSED BY MPU
Jul 10, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 9, 2015 RFCR
NON-FINAL ACTION WRITTEN
Jul 8, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 30, 2015 MAFR
ASSIGNED TO EXAMINER
Jun 27, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 26, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 25, 2015 REPR

Related Trademarks

More from this Owner

QARZIBA

QARZIBA

QARZIBA

QARZIBA

T ACELLT APEIRON CELL THERAPIES logo

T ACELLT APEIRON CELL THERAPIES

ACELLT

ACELLT

ACELLT

ACELLT

ACELLT

ACELLT